Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 7924153, 9 pages
https://doi.org/10.1155/2018/7924153
Research Article

Retrospective Analysis of Intravaginal Brachytherapy in Adjuvant Treatment of Early Endometrial Cancer

1Department of Oncology, Medical University of Lublin, Jaczewskiego 7, Lublin, Poland
2Department of Brachytherapy, St. John’s Oncology Center of Lublin, Jaczewskiego 7, Lublin, Poland
3Department of Gynecology, St. John’s Oncology Center of Lublin, Jaczewskiego 7, Lublin, Poland

Correspondence should be addressed to Paweł Cisek; ue.airetni@kesicp

Received 30 August 2017; Revised 20 December 2017; Accepted 28 December 2017; Published 21 February 2018

Academic Editor: John P. Geisler

Copyright © 2018 Paweł Cisek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. GLOBOCAN: Cancer Incidence and Mortality Worldwide. Lyon: IARC, http://globocan.iarc.fr 2012.
  2. S. Sabater, I. Andres, V. Lopez-Honrubia et al., “Vaginal cuff brachytherapy in endometrial cancer - a technically easy treatment?” Cancer Management and Research, vol. 9, pp. 351–362, 2017. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Mariani, S. C. Dowdy, W. A. Cliby et al., “Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging,” Gynecologic Oncology, vol. 109, no. 1, pp. 11–18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. H. M. Keys, J. A. Roberts, V. L. Brunetto et al., “A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study,” Gynecologic Oncology, vol. 92, no. 3, pp. 744–751, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. C. L. Creutzberg, W. L. van Putten, P. C. Koper et al., “Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial,” The Lancet, vol. 355, no. 9213, pp. 1404–1411, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Blake, A. M. Swart, J. Orton et al., “Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis,” The Lancet, vol. 373, no. 9658, pp. 137–146, 2009. View at Publisher · View at Google Scholar
  7. N. Johnson and P. Cornes, “Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: Systematic review and meta-analysis,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 114, no. 11, pp. 1313–1320, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Kong, I. Simera, M. Collingwood, C. Williams, and H. Kitchener, “Adjuvant radiotherapy for stage I endometrial cancer: Systematic review and meta-analysis,” Annals of Oncology, vol. 18, no. 10, pp. 1595–1604, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Sorbe, B. Nordström, J. Mäenpää et al., “Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: A controlled randomized study,” International Journal of Gynecological Cancer, vol. 19, no. 5, pp. 873–878, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Weiss, P. Hirnle, H. Arnold-Bofinger, C. F. Hess, and M. Bamberg, “Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: Patterns of relapse and side effects following low-dose therapy,” Gynecologic Oncology, vol. 71, no. 1, pp. 72–76, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Chadha, P. J. Nanavati, P. Liu, J. Fanning, and A. Jacobs, “Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy,” Gynecologic Oncology, vol. 75, no. 1, pp. 103–107, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Anderson, B. Stea, A. V. Hallum, E. Rogoff, and J. Childers, “High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer,” International Journal of Radiation Oncology Biology Physics, vol. 46, no. 2, pp. 417–425, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. K. M. Alektiar, E. Venkatraman, D. S. Chi, and R. R. Barakat, “Intravaginal brachytherapy alone for intermediate-risk endometrial cancer,” International Journal of Radiation Oncology Biology Physics, vol. 62, no. 1, pp. 111–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. S. A. McCloskey, N. E. Tchabo, H. K. Malhotra et al., “Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation,” Gynecologic Oncology, vol. 116, no. 3, pp. 404–407, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Ríos, A. Rovirosa, C. Ascaso et al., “Vaginal-cuff control and toxicity results of a daily HDR brachytherapy schedule in endometrial cancer patients,” Clinical and Translational Oncology, vol. 18, no. 9, pp. 925–930, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. R. A. Nout, “Vaginal brachytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: Results of the randomized PORTEC-2 trial,” Clinical Oncology, vol. 26, no. Supplement abstr LBA5503, 2008. View at Publisher · View at Google Scholar
  17. L. L. Lin, D. G. Mutch, J. S. Rader, M. A. Powell, and P. W. Grigsby, “External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer,” Gynecologic Oncology, vol. 106, no. 1, pp. 215–220, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. I. L. Atahan, E. Ozyar, F. Yildiz et al., “Vaginal high dose rate brachytherapy alone in patients with intermediate- to high-risk stage I endometrial carcinoma after radical surgery,” International Journal of Gynecological Cancer, vol. 18, no. 6, pp. 1294–1299, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. C. Solhjem, I. A. Petersen, and M. G. Haddock, “Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer,” International Journal of Radiation Oncology Biology Physics, vol. 62, no. 5, pp. 1379–1384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Cengiz, A. K. Singh, and P. W. Grigsby, “Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1-2, stage IC endometrial cancer,” International Journal of Gynecological Cancer, vol. 15, no. 5, pp. 926–931, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. P. V. C. Rittenberg, R. J. Lotocki, M. S. Heywood, K. D. Jones, and G. V. Krepart, “High-risk surgical stage 1 endometrial cancer: Outcomes with vault brachytherapy alone,” Gynecologic Oncology, vol. 89, no. 2, pp. 288–294, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. N. S. Horowitz, W. A. Peters, M. R. Smith et al., “Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma,” Obstetrics & Gynecology, vol. 99, no. 2, pp. 235–240, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. Á. Rovirosa, A. Herreros, C. Camacho et al., “Comparative results of three short brachytherapy schedules as exclusive treatment in postoperative endometrial carcinoma,” Brachytherapy, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. Á. Rovirosa, C. Ascaso, A. Herreros et al., “A new short daily brachytherapy schedule in postoperative endometrial carcinoma. Preliminary results,” Brachytherapy, vol. 16, no. 1, pp. 147–152, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Townamchai, L. Lee, and A. N. Viswanathan, “A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer,” Gynecologic Oncology, vol. 127, no. 2, pp. 351–355, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Straughn, W. K. Huh, F. Kelly et al., “Conservative management of Stage I endometrial carcinoma after surgical staging,” Gynecologic Oncology, vol. 84, no. 2, pp. 194–200, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. E. F. Dunn, H. Geye, C. S. Platta et al., “Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage i endometrial cancer,” Gynecologic Oncology, vol. 133, no. 3, pp. 494–498, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Aristizabal, O. Graesslin, E. Barranger et al., “A suggested modification to FIGO stage i endometrial cancer,” Gynecologic Oncology, vol. 133, no. 2, pp. 192–196, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. M. Alhilli, J. N. Bakkum-Gamez, A. Mariani et al., “Risk-adjusted outcomes in elderly endometrial cancer patients: Implications of the contrasting impact of age on progression-free and cause-specific survival,” Gynecologic Oncology, vol. 138, no. 1, pp. 133–140, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Arenas, M. Gascón, À. Rovirosa et al., “The effect of lymphadenectomy and radiotherapy on recurrence and survival in endometrial carcinoma. Experience in a population reference centre,” Reports of Practical Oncology and Radiotherapy, vol. 20, no. 1, pp. 50–56, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. M. M. Alhilli, K. C. Podratz, S. C. Dowdy et al., “Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer,” Gynecologic Oncology, vol. 128, no. 2, pp. 294–299, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. N. T. Kizer, F. Gao, S. Guntupalli et al., “Lower uterine segment involvement is associated with poor outcomes in early-stage endometrioid endometrial carcinoma,” Annals of Surgical Oncology, vol. 18, no. 5, pp. 1419–1424, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Chattopadhyay, P. Cross, A. Nayar, K. Galaal, and R. Naik, “Tumor size: A better independent predictor of distant failure and death than depth of myometrial invasion in international federation of gynecology and obstetrics stage I endometrioid endometrial cancer,” International Journal of Gynecological Cancer, vol. 23, no. 4, pp. 690–697, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. O. Lavie, L. Uriev, M. Gdalevich et al., “The outcome of patients with stage I endometrial cancer involving the lower uterine segment,” International Journal of Gynecological Cancer, vol. 18, no. 5, pp. 1079–1083, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Canlorbe, S. Bendifallah, E. Laas et al., “Tumor Size, an Additional Prognostic Factor to Include in Low-Risk Endometrial Cancer: Results of a French Multicenter Study,” Annals of Surgical Oncology, vol. 23, no. 1, pp. 171–177, 2016. View at Publisher · View at Google Scholar · View at Scopus